Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of atorvastatin to prevent first decompensation in high-risk compensated liver cirrhosis
TCTR20250624005Phase 2Enrolling by invitation
- Sponsor
- Faculty of Medicine, Khon Kaen University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in Cirrhosis, sponsored by Faculty of Medicine, Khon Kaen University. Started Jun 2025; status: enrolling by invitation.
02
Drugs
atorvastatin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on TCTR20250624005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250624005.